In a significant development for the medical technology sector, the Federal Circuit has reinstated Recor Medical’s challenge against a patent held by Medtronic Ireland Manufacturing. The patent in question involves a method for treating heart and renal failure. This decision requires the Patent Trial and Appeal Board (PTAB) to re-examine aspects of the patent dispute. To better understand the intricacies of this legal battle, you can read more about it through the detailed coverage offered by Law360.